DGCR2

gene product
DGS-C, IDD, KIAA0163, LAN, SEZ-12
Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
148 antibodies from 22 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
antibodies-online
57 antibodies
Novus Biologicals
5 antibodies
Invitrogen Antibodies
4 antibodies
Atlas Antibodies
2 antibodies
GeneTex
1 antibody
NovoPro Bioscience Inc.
1 antibody
Aviva Systems Biology
3 antibodies
LifeSpan BioSciences, Inc.
23 antibodies
OriGene
3 antibodies
Biorbyt
4 antibodies
Creative Biolabs
4 antibodies
Abnova Corporation
2 antibodies
Acris Antibodies GmbH
1 antibody
ProSci
2 antibodies
Boster Biological Technology
1 antibody
St John's Laboratory
1 antibody
MyBioSource
3 antibodies
Creative Diagnostics
2 antibodies
Sigma-Aldrich
3 antibodies
United States Biological
13 antibodies